ED
KERX

Exane Derivatives’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Exane Derivatives’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,259
Closed -$4.41K – 721
2018
Q3 		$4.41K Sell
1,259
-24,247
-95% -$84.8K ﹤0.01% 431
2018
Q2 		$92.2K Hold
25,506
– – 0.02% 316
2018
Q1 		$101K Buy
+25,506
New +$101K 0.02% 285